期刊文献+

STAT3在人喉鳞状细胞癌中的表达及意义 被引量:1

Expression and significance of STAT3 in laryngeal squamous cell cancer
下载PDF
导出
摘要 目的:研究信号转导与转录活化因子3(signal transducers and activators of transcription 3,STAT3)在人喉鳞状细胞癌(简称喉癌)组织中的表达,探讨其在喉癌发生发展中的作用。方法:应用免疫组化SP法检测12例正常喉组织及38例喉癌组织中STAT3的阳性表达情况。结果:STAT3阳性表达主要定位于细胞浆,STAT3蛋白在喉癌组织中的阳性细胞表达率(44.05%±13.82%)高于正常喉黏膜组织(6.40%±1.77%),其差异具有统计学意义(P<0.01)。中、低分化伴颈部淋巴结转移的喉癌组织中STAT3阳性细胞表达率显著高于高分化、无颈部淋巴结转移的喉癌组织(P<0.05)。结论:STAT3在喉癌组织的高表达可能与喉癌的发生、发展密切相关。 OBJECTIVE:To explore the expression and significance of signal transducers and activators of transcription 3(STAT3) in laryngeal squamous cell cancer. METHODS: Immunohistochemical technique was used to examine expression of STAT3 in 12 normal tissues and 38 laryngeal cancer. RESULTS: Positive staining of STAT3 was localized in the cytoplasm. The positive rate of STAT3 in 38 laryngeal cancer was significantly higher than those in 12 normal tissues(P0.01). Overexpression of STAT3 protein was tested in those cancers with lymph nodes metastasis(P0.05), and had a close relationship with histological grades(P0.05). CONCLUSION: Overexpression of STAT3 might have a close correlation with the development of laryngeal squamous cell carcinoma.
出处 《癌变.畸变.突变》 CAS CSCD 2010年第2期112-114,118,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
关键词 喉肿瘤 信号转导与转录活化因子3 laryngeal neoplasms carcinoma signal transducers and activators of transcription 3
  • 相关文献

参考文献18

  • 1Campbell CL, Jiang Z , Savarese DM, et al. Increased expression of the interleukin -11 receptor and evidence of STAT3 activation in prostate carcinoma [J] Am J Pathol, 2001,158(1) :25 - 32.
  • 2Bowman T, Caroia R, Turkson J, et al. STATs in oncogenesis [J]. Oncogene, 2000,19(21):2474-2488.
  • 3郑美桦,田晓东,李虎,程雅莉,陈秀红.咽喉鳞癌组织中增殖细胞核抗原和核仁组成区相关嗜银蛋白的表达[J].临床耳鼻咽喉科杂志,2002,16(12):653-655. 被引量:14
  • 4唐古生,蔡建明,韩玲.STAT3与肿瘤治疗[J].实用肿瘤杂志,2004,19(3):257-260. 被引量:2
  • 5Benekli M, Baer MR , Baumann H , et al . Signal transducer and activator of transcription proteins in leukemias [J]. Blood , 2003, 101(8) :2940- 2954.
  • 6Grandis JR , Drenning SD , Zeng Q , et al . Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo[J] . Proc Natl Aead Sci USA , 2000,97(8) :4227- 4232.
  • 7Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells [J] . Immunity, 1999,10(1) : 105- 115.
  • 8Burdelya L, Kujawski M, Niu G, et al. Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects[J] Immunol, 2005, 174(7) : 3925 - 3931.
  • 9Leong PL, Andrews GA, Johnson DE, et al. Targeted inhibition of STAT3 with a decoy oligonneleotide abrogates head and neck cancer cell growth[J] .Proc Natl Acad Sci USA, 2003,100(7) :4138 - 4143.
  • 10Gareia R, Bowman TL, Niu G, et al. Constitutive activation of STAT3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells [J]. Oncogene, 2001,20(20) : 2499 - 2513.

二级参考文献38

  • 1俞丽芬,朱延波,乔敏敏,钟捷,涂水平,吴云林.Stat3在人胃癌细胞株和组织中的组成性激活及其临床意义[J].中华医学杂志,2004,84(24):2064-2069. 被引量:29
  • 2张真发,马建群,张林.非小细胞肺癌中的STAT3和ras-MAPK信号通路[J].中国肺癌杂志,2005,8(1):23-27. 被引量:1
  • 3许良中.关于核仁组织区(AgNOR)研究工作的标准化方案[J].中国肿瘤临床,1996,23(5):377-377.
  • 4Kisseleva T,Bhattacharya S,Braunstein,J et al.Signaling through the JAK/STAT pathway,recent advances and future changes[J].Gene,2002,285(1-2),1-24.
  • 5Buettner R,Mora LB,Jove R.Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J].Clin Cancer Res,2002,8(4):945-954.
  • 6Decker T,Kovarik P.Serine phosphorylation of STATs[J].Oncogene,2000,19(21):2628-2637.
  • 7Bromberg JF,Wrzeszczynska MH,Devgan G,et al.STAT3 as an oncogene[J].Cell,1999,98(3):295-303.
  • 8Niu G,Wright KL,Huang M,et al.Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis[J].Oncogene,2002,21 (13):2000-2008.
  • 9Bowman T,Garcia R,Turkson J.STATs in oncogenesis[J].Oncogene,2000,19(2l):2474-2488.
  • 10Bromberg J.Stat proteins and oncogenesis[J].J Clin Invest,2002,109(9):1139-1142.

共引文献41

同被引文献11

  • 1王禹,张颖超,韩喜春,关文曾.乳腺癌组织中癌基因STAT3的表达及临床意义[J].中国老年学杂志,2005,25(9):1036-1037. 被引量:6
  • 2于晓棠,朱世能,朱腾方,陈洁晴,陆世伦.EGFR-STAT3信号通路在大鼠实验性肝癌发生中的作用[J].中国癌症杂志,2006,16(2):107-111. 被引量:4
  • 3王新华,李珊珊,阎爱华,卢创新,郭燕萍.STAT3在食管鳞癌细胞系中的激活及其靶基因产物的表达[J].南方医科大学学报,2006,26(4):441-444. 被引量:8
  • 4李钦,陈奎生,张国俊,高冬玲.食管鳞癌组织中胰岛素样生长因子-Ⅱ蛋白的表达[J].郑州大学学报(医学版),2006,41(3):559-561. 被引量:6
  • 5Yu H, Jove R. The STATs of cancer--new molecular targets come of age [J]. Nat Rev Cancer, 2004, 4 (2): 97-105.
  • 6Cortas T, Eisenberg R, Fu P, et al. Activation state egfr and STAT-3 as prognostic, markers in resected non-small cell lung cancer [J]. Lung Cancer, 2007, 55 (3):349-355.
  • 7KlosekSK, Nakashiro K, Hara S, et al. Stat3 molecular target in RNA interference-based treatment of oral squamous cell carcinoma[J]. Oncol Rep, 2008, 20 (4): 873-878.
  • 8Yin ZJ, Jin FG, Liu TG, et al. Overexpression of STAT3 Potentiates growth, survival, and radioresistance of non- small-cell lung cancer (NSCLC) cells [J].J Surg Res, 2010, Apr, 18 [Epub ahead of print].
  • 9Lo HW, Hsu SC, Ali-Seyed M, et al. Nuclear interaction of EGFR and STAT3 in the activation Of the iNOS/NO pathway [J]. Cancer Cell, 2005, 7 (6): 575-589.
  • 10Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience[J]. Ann Oncol, 2004, 15 (6): 875-884.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部